0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nucleic Acids"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
From
EUR$4,500USDGBP
Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025 - Product Thumbnail Image

Antisense Oligonucleotide Therapeutics - Pipeline Insight, 2025

  • Drug Pipelines
  • July 2025
  • 280 Pages
  • Global
From
EUR$3,000USDGBP
From
EUR$3,750USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
From
EUR$3,850USDGBP
EUR$4,850USDGBP
Emerging Medical Technologies Spotlight - Product Thumbnail Image

Emerging Medical Technologies Spotlight

  • Newsletter
  • August 2025
  • Global
EUR$2,995USDGBP
From
EUR$4,850USDGBP
From
EUR$3,839USDGBP
EUR$4,799USDGBP
Loading Indicator

Nucleic acids are molecules that are essential for life and are found in all living organisms. They are the building blocks of DNA and RNA, and are used in biotechnology for a variety of applications, such as gene therapy, diagnostics, and drug discovery. Nucleic acid-based technologies are used to identify, analyze, and manipulate genetic material. The nucleic acids market is a rapidly growing segment of the biotechnology industry. It is driven by advances in sequencing technology, which has enabled the development of new applications and products. The market is also driven by the increasing demand for personalized medicine, which requires the use of nucleic acid-based technologies. Companies in the nucleic acids market include Thermo Fisher Scientific, Illumina, Agilent Technologies, Qiagen, and Bio-Rad Laboratories. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more